Menovo(SH:603538)2022-04-25 16:00Financial Performance - The company's operating revenue for Q1 2022 was ¥500,209,863.60, representing a year-on-year increase of 47.86%[5] - Net profit attributable to shareholders for the same period was ¥115,262,819.38, reflecting a significant increase of 128.94% compared to the previous year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥108,892,837.46, up 142.75% year-on-year[5] - The net cash flow from operating activities reached ¥52,664,102.21, a remarkable increase of 381.04%[5] - The net profit for Q1 2022 was CNY 126,813,489.39, a significant increase of 134% compared to CNY 53,845,524.75 in Q1 2021[21] - The total revenue from operating activities reached CNY 351,455,266.33, up from CNY 236,104,257.15 in the same period last year, representing a growth of approximately 49%[25] - The operating profit for Q1 2022 was CNY 143,525,351.09, compared to CNY 62,682,715.24 in Q1 2021, indicating a year-over-year increase of 128%[21] - The company reported a total comprehensive income of CNY 127,079,016.39 for Q1 2022, compared to CNY 53,748,914.34 in Q1 2021, reflecting an increase of 136%[22] Earnings Per Share - Basic earnings per share for the period were ¥0.76, compared to ¥0.42 in the same period last year[6] - Diluted earnings per share increased to ¥0.70 from ¥0.36 year-on-year[6] - Basic earnings per share for Q1 2022 were CNY 0.76, up from CNY 0.34 in Q1 2021, marking a growth of 124%[22] Assets and Liabilities - Total assets at the end of the reporting period were ¥4,163,321,849.23, up 4.04% from the end of the previous year[6] - Total assets as of March 31, 2022, were RMB 4,163,321,849.23, an increase from RMB 4,001,495,468.56 at the end of 2021[17] - Total liabilities as of March 31, 2022, were RMB 2,010,062,969.44, a slight decrease from RMB 2,022,990,166.99 at the end of 2021[16] - The company's equity attributable to shareholders as of March 31, 2022, was RMB 1,911,704,445.39, up from RMB 1,751,483,976.45 at the end of 2021[17] Cash Flow - Cash and cash equivalents as of March 31, 2022, were RMB 429,284,022.83, slightly up from RMB 421,787,093.24 at the end of 2021[14] - The cash and cash equivalents at the end of Q1 2022 amounted to CNY 380,939,246.25, an increase from CNY 209,931,228.22 at the end of Q1 2021[27] - The cash flow from operating activities generated a net amount of CNY 52,664,102.21, a turnaround from a negative cash flow of CNY -18,738,767.96 in Q1 2021[26] - Investment activities resulted in a net cash outflow of CNY -101,364,941.96 in Q1 2022, compared to CNY -515,062,217.35 in Q1 2021, indicating an improvement in cash flow management[26] Costs and Expenses - Total operating costs for Q1 2022 were RMB 365,195,193.49, up 29.4% from RMB 282,292,447.78 in Q1 2021[20] - Research and development expenses for Q1 2022 amounted to RMB 8,531,863.08, a decrease of 35.5% from RMB 13,210,864.94 in Q1 2021[20] - The company incurred interest expenses of CNY 6,420,495.97 in Q1 2022, a decrease from CNY 6,955,336.01 in Q1 2021, showing a reduction of approximately 8%[21] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 49,077[11] - Inventory as of March 31, 2022, was RMB 577,986,471.00, a slight decrease from RMB 579,688,837.50 at the end of 2021[15] - Short-term borrowings as of March 31, 2022, were RMB 417,661,600.00, down from RMB 425,866,700.00 at the end of 2021[16] Profitability Metrics - The company reported a gross profit margin of 40.49% for the period, driven by strong sales growth in its CDMO and formulation businesses[8] - Gross profit for Q1 2022 was RMB 135,014,670.11, reflecting a gross margin of approximately 27%[20] - The weighted average return on equity rose to 6.37%, an increase of 3.33 percentage points[6]